These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 205324)

  • 21. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neurological basis of motor asymmetry following unilateral nigrostriatal lesions in the rat: the effect of secondary superior colliculus lesions.
    Crossman AR; Sambrook MA
    Brain Res; 1978 Dec; 159(1):211-3. PubMed ID: 569529
    [No Abstract]   [Full Text] [Related]  

  • 23. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
    Di Chiara G; Morelli M; Porceddu ML; Gessa GL
    Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
    [No Abstract]   [Full Text] [Related]  

  • 25. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 26. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of dopamine release by the autoreceptor after repeated methamphetamine treatment in rats: an intracerebral dialysis study.
    Kazahaya Y; Hamamura T; Otsuki S
    Jpn J Psychiatry Neurol; 1988 Dec; 42(4):839-43. PubMed ID: 3249477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 30. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors.
    Argiolas A; Mereu G; Serra G; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Jan; 231(1):109-16. PubMed ID: 6799148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle.
    Ingvar M; Lindvall O; Stenevi U
    Brain Res; 1983 Mar; 262(2):259-65. PubMed ID: 6404503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs.
    Euvrard C; Labrie F; Boissier JR
    Brain Res; 1979 Jun; 169(1):215-20. PubMed ID: 455094
    [No Abstract]   [Full Text] [Related]  

  • 33. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of striatal dopamine receptors induces pain inhibition in rats.
    Lin MT; Wu JJ; Chandra A; Tsay BL
    J Neural Transm; 1981; 51(3-4):213-22. PubMed ID: 7288429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal: evidence for dopaminergic supersensitivity in protracted abstinence.
    Gianutsos G; Hynes MD; Puri SK; Drawbaugh RB; Lal H
    Psychopharmacologia; 1974 Jan; 34(1):37-44. PubMed ID: 4856259
    [No Abstract]   [Full Text] [Related]  

  • 36. One-trial conditioned rotation in rats.
    Silverman PB
    NIDA Res Monogr; 1989; 95():540-1. PubMed ID: 2577050
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons.
    Wood PL; McQuade PS; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):765-8. PubMed ID: 6141617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra.
    Crocker AD
    Rev Neurosci; 1997; 8(1):55-76. PubMed ID: 9402645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for, and localization of, a unitary dopamine receptor composed of cooperatively linked subunit binding sites in rat striatum.
    Leysen JE; Gommeren W; Laduron PM
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):312-4. PubMed ID: 543764
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.